Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric EVARREST study for surgical bleeding control
2019-004657-89Phase 3Unknown
- Sponsor
- Ethicon
- Start
- Oct 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Fibrinogen human in None and spontaneous hepatic hemorrhage (SHH), sponsored by Ethicon. Primary endpoint: Absolute time to hemostasis. Status: unknown.
02
Drugs
Fibrinogen human
03
Conditions
spontaneous hepatic hemorrhage (SHH)
Beyond the preview
Go deeper on 2019-004657-89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004657-89.